ESGO-ESTRO-ESP 2025 Endometrial Cancer Guidelines with Nicole Concin

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss ESGO-ESTRO-ESP 2025 Endometrial Cancer Guidelines.



 



Professor Concin serves as the Chair of the Department of Gynaecology and Gynaecological Oncology and as Director of the Department of Obstetrics and Gynaecology at the Medical University of Vienna. She is President of the Austrian Network of Gynaecologic Oncology (AGO Austria), Executive Committee member of

the European Society of Gynaecological Oncology (ESGO), immediate Past-President of the ESGO, Board of Directors member of GCIG Gynaecologic Cancer InterGroup (GCIG), education faculty member for gynaecological cancer of the European Society of Medical Oncology (ESMO) and Board member of the International Federation of Gynaecology and Obstetrics (FIGO) Committee on Women’s Cancer.



Professor Concin’s clinical, research and teaching focus is gynaecological oncology. She has led multiple translational and clinical research projects worldwide and provided her expertise in ＞100 international clinical trials in gynaecological oncology, several of which she served as Principal or Global Coordinating Investigator. She has authored ＞150 research articles inhighly ranked peer-reviewed Journals. Her most cited article is the European multidisciplinary guidelines for the management of patients with endometrial carcinoma (Concin N. et al, IJGC Dec 2020; ＞1300 citations). In recognition of Professor Concin’s ability and achievements, she has received multiple grants and awards including the award of the Austrian Society for Cancer Aid, i.e. the Univ. Prof. DDr. Karl Fellinger Award. Her recent article in Lancet Oncology, “ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: Update 2025,” presents the latest revision of the guidelines, building upon the previous version published in 2021.